From acute decompensated to chronic heart failure

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

An acute decompensation of heart failure resulting in hospital admission represents a critical juncture in the natural history of the disease, as evidenced by poor mortality and readmission outcomes after hospital discharge. For this reason, a number of new short-term vasoactive therapies have been or are being tested in clinical trials. Furthermore, in response to unacceptable readmission rates, there has been intense interest in improving the transition from hospital discharge to the outpatient arena. Between these 2 areas of focus exists an often overlooked internal transition from acute vasoactive therapies to oral chronic heart failure medications. This transition from acute presentation to the rest of the hospital stay forms the basis of this review.

Original languageEnglish (US)
Pages (from-to)1923-1929
Number of pages7
JournalAmerican Journal of Cardiology
Volume114
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Heart Failure
Length of Stay
Outpatients
Clinical Trials
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

From acute decompensated to chronic heart failure. / Patel, Snehal R.; Pina, Ileana L.

In: American Journal of Cardiology, Vol. 114, No. 12, 2014, p. 1923-1929.

Research output: Contribution to journalArticle

@article{050cdc61d19d4cabb9652b807895aa0c,
title = "From acute decompensated to chronic heart failure",
abstract = "An acute decompensation of heart failure resulting in hospital admission represents a critical juncture in the natural history of the disease, as evidenced by poor mortality and readmission outcomes after hospital discharge. For this reason, a number of new short-term vasoactive therapies have been or are being tested in clinical trials. Furthermore, in response to unacceptable readmission rates, there has been intense interest in improving the transition from hospital discharge to the outpatient arena. Between these 2 areas of focus exists an often overlooked internal transition from acute vasoactive therapies to oral chronic heart failure medications. This transition from acute presentation to the rest of the hospital stay forms the basis of this review.",
author = "Patel, {Snehal R.} and Pina, {Ileana L.}",
year = "2014",
doi = "10.1016/j.amjcard.2014.09.033",
language = "English (US)",
volume = "114",
pages = "1923--1929",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - From acute decompensated to chronic heart failure

AU - Patel, Snehal R.

AU - Pina, Ileana L.

PY - 2014

Y1 - 2014

N2 - An acute decompensation of heart failure resulting in hospital admission represents a critical juncture in the natural history of the disease, as evidenced by poor mortality and readmission outcomes after hospital discharge. For this reason, a number of new short-term vasoactive therapies have been or are being tested in clinical trials. Furthermore, in response to unacceptable readmission rates, there has been intense interest in improving the transition from hospital discharge to the outpatient arena. Between these 2 areas of focus exists an often overlooked internal transition from acute vasoactive therapies to oral chronic heart failure medications. This transition from acute presentation to the rest of the hospital stay forms the basis of this review.

AB - An acute decompensation of heart failure resulting in hospital admission represents a critical juncture in the natural history of the disease, as evidenced by poor mortality and readmission outcomes after hospital discharge. For this reason, a number of new short-term vasoactive therapies have been or are being tested in clinical trials. Furthermore, in response to unacceptable readmission rates, there has been intense interest in improving the transition from hospital discharge to the outpatient arena. Between these 2 areas of focus exists an often overlooked internal transition from acute vasoactive therapies to oral chronic heart failure medications. This transition from acute presentation to the rest of the hospital stay forms the basis of this review.

UR - http://www.scopus.com/inward/record.url?scp=84964262327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964262327&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2014.09.033

DO - 10.1016/j.amjcard.2014.09.033

M3 - Article

VL - 114

SP - 1923

EP - 1929

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 12

ER -